New data reinforces Ipsens commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14 abstracts will be presented across a range of neurological conditions including…
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
Weaviate named a Leader and Outperformer by GigaOm and Emerging Leader by Gartner; Market Momentum Accelerates as Nonrelational DBMS Segment Grows 22.7%
Amsterdam City, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Weaviate, the AI database…
CORRECTION Visionary Holdings Inc.
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under…
Renderforest 1.0 Strengthens Global Creative Production With Unified AI System
Renderforest expands its platform with its own proprietary AI model, enabling text,…
Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis
Not intended for US and UK audiences BI 765423 has been developed…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
January 13, 2026 07:05 ET | Source: Treace Medical Concepts, Inc. PONTE…
Rocket Doctor Announces Granting of RSUs and Options
January 12, 2026 20:03 ET | Source: Rocket Doctor AI Inc. Vancouver,…
Washington Business Journals Names Brian Ferdinand as a 2026 Projected Breakout Trader
Washington, DC, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Washington Business Journals has…
